• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 86 Day 1 on September 24; Register to live stream

    9/23/25 7:00:00 AM ET
    $ADVM
    $AIIO
    $BANL
    $BNZI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Auto Manufacturing
    Industrials
    Get the next $ADVM alert in real time by email

    MIAMI, Sept. 23, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 86th Emerging Growth Conference on September 24 & 25, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 - Wednesday

    September 24, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Eshallgo, Inc. (NASDAQ:EHGO)

    Keynote speakers: Johnny Wu, President

    9:40 – 10:10

    Kneat.com, Inc., (OTCQX:KSIOF) (TSX:KSI)

    Keynote speaker: Edmund Ryan, CEO

    10:15 – 10:45

    Robo.ai Inc. (NASDAQ:AIIO)

    Keynote speaker: Benjamin Bin Zhai - CEO & Executive Director

    10:50 – 11:20

    Zapp Electric Vehicles Group, Ltd. (OTCQB:ZAPPF)

    Keynote speaker: David McIntyre, CEO

    11:25 – 11:55

    BluSky AI Inc. (OTCID: BSAI)

    Keynote speaker: Trent D'Ambrosio, Founder, CEO, and Dan Gray, COO

    12:00 – 12:30

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    12:35 – 1:05

    Stallion Uranium Corp. (OTCQB:STNLF) (TSXV:STUD) 

    Keynote speaker: Darren Slugoski, VP Exploration

    1:10 – 1:40

    CBL International Limited (NASDAQ:BANL)

    Keynote speaker: Dr. Teck Lim CHIA, William, Chairman and Chief Executive, and Ms. Venus Zhao, IR & PR Director

    1:45 – 2:15

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO

    2:55 – 3:05

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    3:10 – 3:20

    Adverum Biotechnologies (NASDAQ:ADVM)

    Keynote speaker: Jason Awe, PhD, MBA, Corporate Communications & IR

    3:40 – 3:50

    Banzai International, Inc. (NASDAQ:BNZI)

    Keynote speaker: Joseph Davy, Co-Founder, Chairman & CEO

    3:55 – 4:05

    Aurora Mobile Limited (NASDAQ:JG)

    Keynote speaker: Shan-Nen Bong, CFO

    4:10 – 4:20

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden, VP Corporate Development

    4:25 – 4:35

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    _______________________________________________________________

    Day 2 – Thursday

    September 25, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    SBC Medical Group Holdings, Inc. (NASDAQ:SBC)

    Keynote speaker: Yuya Yoshida, Executive Vice President & CFO

    10:15 – 10:45

    Autris (OTCID: AUTR)

    Keynote speakers: Don Morrison, CFO, & Dan Patrick, CEO

    10:50 – 11:20

    First Phosphate Corp. (CSE:PHOS) (OTCQB:FRSPF)

    Keynote speaker: John Passalacqua, CEO

    11:25 – 11:55

    Tivic Health Systems, Inc.'s (NASDAQ:TIVC)

    Keynote speaker: Jennifer Ernst, Co-Founder, CEO

    12:00 – 12:30

    Questcorp Mining, Inc. (OTCQB:QQCMF) (CSE:QQQ)

    Keynote speaker: Saf Dhillon - CEO, President & Director

    12:35 – 1:05

    iMetal Resources, Inc. (OTCQB:IMRFF) (TSXV:IMR)

    Keynote speaker: Saf Dhillon - CEO, President & Director

    1:10 – 1:40

    StrikePoint Gold, Inc.'s (OTCQB:STKXF) (TSXV:SKP)

    Keynote speaker: Michael Gregory Allen, CEO, President & Director

    1:45 – 2:15

    Vivani Medical, (NASDAQ:VANI)

    Keynote speaker: Adam Mendelsohn PHD, CEO

    2:20 – 2:50

    Lifeloc Technologies, Inc. (OTCID: LCTC)

    Keynote speaker: Wayne Willkomm, President / CEO

    2:55 – 3:05

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    3:10 - 3:20

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    3:25 – 3:35

    Medicenna Therapeutics Corp. (OTCQX:MDNAF) (TSX:MDNA)

    Keynote speaker: Fahar Merchant, President and CEO

    3:40 – 3:50

    Surf Air Mobility, Inc. (NYSE:SRFM)

    Keynote speakers: Deanna White, CEO and Oliver Reeves, CFO

    3:55 – 4:05

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $AIIO
    $BANL
    $BNZI

    CompanyDatePrice TargetRatingAnalyst
    SBC Medical Group Holdings Incorporated
    $SBC
    3/6/2026$8.00Buy
    BTIG Research
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    Surf Air Mobility Inc.
    $SRFM
    4/2/2025$3.25Hold → Buy
    Canaccord Genuity
    GeoVax Labs Inc.
    $GOVX
    11/11/2024$15.00Buy
    Alliance Global Partners
    GeoVax Labs Inc.
    $GOVX
    7/16/2024$20.00Buy
    ROTH MKM
    More analyst ratings

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Gordon Mark

    4 - ODYSSEY MARINE EXPLORATION INC (0000798528) (Issuer)

    3/24/26 4:05:03 PM ET
    $OMEX
    Marine Transportation
    Consumer Discretionary

    SEC Form 4 filed by Zajac Mark L.

    4 - US ENERGY CORP (0000101594) (Issuer)

    3/20/26 4:33:01 PM ET
    $USEG
    Oil & Gas Production
    Energy

    SEC Form 4 filed by Smith Ryan Lewis

    4 - US ENERGY CORP (0000101594) (Issuer)

    3/20/26 4:32:16 PM ET
    $USEG
    Oil & Gas Production
    Energy

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SBC Medical Announces Next-Generation Wellness Strategy "SBC Wellness 2.0"

    Pioneering the "Performance Medicine" category for full-scale entry into the longevity market — targeting a global market projected to reach $2 trillion by 2035 SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced "SBC Wellness 2.0," a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323000188/en/SBC Medical Announces Next-Generation Wellness

    3/24/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    Robo.ai Initiates Revenue Recognition for Intelligent Data Business and Advances Tens of Thousands of Hours of Capacity Cooperation Across the Middle East and Asia

    DUBAI, UAE, March 24, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ:AIIO) (the "Company" or "Robo.ai") today announced the capacity expansion plan for its intelligent data business segment. Following the delivery of its initial batch of real-world interaction data and the initiation of the revenue recognition process in the first quarter of this year, the Company plans to advance this business line into a scaled capacity phase. To achieve a baseline delivery target of 10,000 hours of real-world interaction data in 2026 and to address the artificial intelligence industry's continued demand for structured data, Robo.ai is leveraging regional resources across the Middle East and Asia to establish a

    3/24/26 6:57:00 AM ET
    $AIIO
    Auto Manufacturing
    Industrials

    Banzai Reaches Deal to Acquire Assets of ConnectAndSell, a Profitable Company, More Than Doubling Annual Revenue and Expanding AI Platform Capabilities

    ConnectAndSell is a Leading AI Sales Acceleration Platform Serving B2B Organizations Across Healthcare, Financial Services & Technology Industries Proposed Acquisition Strengthens Banzai's Marketing and Sales Software Platform with Established Revenue-Generating Business Expected to Close in Q2 - 2026 and Management to Review on Upcoming Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time SEATTLE, March 23, 2026 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ:BNZI) ("Banzai" or the "Company"), a leading AI marketing technology company, today announced that it has reached an agreement on terms to acquire assets of ConnectAndSell, Inc. ("ConnectandSell"), an AI-pow

    3/23/26 9:30:00 AM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Gregg bought $1,683,335 worth of shares (1,575,231 units at $1.07) (SEC Form 4)

    4 - Vivani Medical, Inc. (0001266806) (Issuer)

    3/16/26 6:15:46 AM ET
    $VANI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Williams Gregg bought $1,983,333 worth of shares (1,866,492 units at $1.06) (SEC Form 4)

    4 - Vivani Medical, Inc. (0001266806) (Issuer)

    2/17/26 6:01:47 AM ET
    $VANI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Williams Gregg bought $1,999,999 worth of shares (1,351,351 units at $1.48) (SEC Form 4)

    4 - Vivani Medical, Inc. (0001266806) (Issuer)

    1/28/26 10:01:22 AM ET
    $VANI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on SBC Medical Group with a new price target

    BTIG Research initiated coverage of SBC Medical Group with a rating of Buy and set a new price target of $8.00

    3/6/26 8:35:41 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $AIIO
    $BANL
    $BNZI
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Citizens Inc.

    SCHEDULE 13G - CITIZENS, INC. (0000024090) (Subject)

    3/25/26 7:45:46 PM ET
    $CIA
    Life Insurance
    Finance

    Tivic Health Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Tivic Health Systems, Inc. (0001787740) (Filer)

    3/25/26 4:25:57 PM ET
    $TIVC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form DEF 14A filed by Jaguar Health Inc.

    DEF 14A - Jaguar Health, Inc. (0001585608) (Filer)

    3/24/26 5:06:18 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Leadership Updates

    Live Leadership Updates

    View All

    SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging Medical Big Data from 283 Global Locations and 6.63 Million Annual Patient Visits to Build a Scalable, AI-Driven Medical Management Infrastructure

    SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a global provider of comprehensive consulting and management services to medical corporations and their clinics, today announced the appointment of Sheng-FU Hsiao as Chief Technology Officer (CTO), effective March 1, 2026. This appointment aligns with the Company's 2026 management strategy, "Sophistication of Management Structure through AI and DX," and strengthens its leadership team to accelerate technological transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302064873/en/SBC Medical Appoints Sheng-FU Hsiao as CTO Leveraging

    3/2/26 7:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care

    CBL Appoints Mr. Yuan He to Board of Directors

    KUALA LUMPUR, Nov. 19, 2025 (GLOBE NEWSWIRE) -- CBL International Limited (NASDAQ:BANL) (the "Company" or "CBL"), the listing vehicle of the Banle Group ("Banle" or "the Group"), a leading marine fuel logistics company in the Asia-Pacific region, is pleased to announce the appointment of Mr. Yuan He to its board of directors, effective December 1, 2025. Mr. Yuan He has been serving as senior vice president of the Company and its predecessor entity since the inception of the Group in 2015. He is primarily responsible for the bunkering business division and the Group's management and strategic development. With over 17 years of experience in the oil and gas-related industries and business m

    11/19/25 7:30:00 AM ET
    $BANL
    Oil Refining/Marketing
    Energy

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:40:56 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $AIIO
    $BANL
    $BNZI
    Financials

    Live finance-specific insights

    View All

    Banzai Reaches Deal to Acquire Assets of ConnectAndSell, a Profitable Company, More Than Doubling Annual Revenue and Expanding AI Platform Capabilities

    ConnectAndSell is a Leading AI Sales Acceleration Platform Serving B2B Organizations Across Healthcare, Financial Services & Technology Industries Proposed Acquisition Strengthens Banzai's Marketing and Sales Software Platform with Established Revenue-Generating Business Expected to Close in Q2 - 2026 and Management to Review on Upcoming Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time SEATTLE, March 23, 2026 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ:BNZI) ("Banzai" or the "Company"), a leading AI marketing technology company, today announced that it has reached an agreement on terms to acquire assets of ConnectAndSell, Inc. ("ConnectandSell"), an AI-pow

    3/23/26 9:30:00 AM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    Banzai to Host Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time

    SEATTLE, March 18, 2026 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ:BNZI) ("Banzai" or the "Company"), a leading AI-powered sales & marketing technology company, will hold a conference call on Tuesday, March 31, 2026, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter ended December 31, 2025, as well as review ongoing initiatives and anticipated milestones. Banzai Founder & CEO Joe Davy and CFO Dean Ditto will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company's website he

    3/18/26 8:31:00 AM ET
    $BNZI
    Computer Software: Prepackaged Software
    Technology

    SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results

    IRVINE, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (NASDAQ:SBC) ("SBC Medical" or the "Company"), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced it will release its financial results for the fourth quarter and fiscal year ended December 31, 2025, before U.S. market open on March 27, 2026.  Management will host an earnings conference call on March 27, 2026, at 8:30 a.m. Eastern Time to discuss the Company's financial performance, operational highlights, and key priorities for 2026. A question‑and‑answer session with analysts and investors will follow the prepared remark

    3/13/26 8:00:00 AM ET
    $SBC
    Medical/Nursing Services
    Health Care